Company: BIAF
Filing Date: 2025-04-22
Form Type: 424B3
Source: 0001641172-25-005598
Chunk: 76

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-04-22
Form: 424B3
Chunk 76
---
 the Securities Act creates concurrent jurisdiction
for federal and state courts over all suits brought to enforce any duty or liability created by the Securities Act or the rules and regulations
thereunder. However, our Charter and our A&R Bylaws contain a federal forum provision which provides that unless we consent in writing
to the selection of an alternative forum, the federal district courts of the U.S. will be the exclusive forum for the resolution of any
complaint asserting a cause of action arising under the Securities Act. We note, however, that there is uncertainty as to whether a court
would enforce this provision and that investors cannot waive compliance with the federal securities laws and the rules and regulations
thereunder.

Any person or entity purchasing or otherwise acquiring
any interest in any of our securities shall be deemed to have notice of and consented to this provision. This exclusive forum provision
may limit a stockholder’s ability to bring a claim in a judicial forum of its choosing for disputes with us or our directors, officers,
or other employees, which may discourage lawsuits against us and our directors, officers, and other employees. If a court were to find
the exclusive forum provision in our Charter to be inapplicable or unenforceable in an action, we may incur additional costs associated
with resolving the dispute in other jurisdictions, which could harm our results of operations.

Certain limitation-of-liability and indemnification provisions in our Charter and A&R Bylaws may discourage stockholders from bringing a lawsuit against our directors and officers for breaches of their fiduciary duties, may reduce the likelihood of derivative litigation against our directors and officers, even though an action, if successful, might benefit the Company and other stockholders, and may adversely impact stockholders’ investments to the extent that the Company pays the costs of settlement and damage awards against directors and officers as required by these indemnification provisions.

Our Charter contains provisions that limit the liability
of our directors for monetary damages to the fullest extent permitted by the DGCL. Consequently, our directors will not be personally
liable to us or our stockholders for monetary damages for any breach of fiduciary duties as directors, except liability for:

| ● | any breach of the director’s duty of loyalty to us or our stockholders; |

| 34 |

| ● | any act or omission not in good faith or that involves intentional misconduct or a knowing violation of law;           |
| ● | unlawful payments of dividends or unlawful stock repurchases or redemptions as provided in Section 174 of the DGCL;